Opioid Use Disorder Clinical Trials

Find Opioid Use Disorder Clinical Trials Near You

Effects of E-Cigarette Flavors on Adult E-Cigarette Users With Opioid Use Disorder Receiving Buprenorphine

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY

This study examines the effects of e-cigarette (EC) flavors among adults with opioid use disorder (OUD) receiving buprenorphine treatment who currently use e-cigarettes. Participants will smell and rate 11 EC flavors based on appeal, sensory characteristics, and likelihood of future use. Researchers will examine how different flavor profiles influence the appeal and reinforcing effects of ECs in this population. The goal is to identify EC flavors that may enhance the acceptability of ECs as a potential harm-reduction strategy among adults with OUD receiving buprenorphine treatment.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 21
Healthy Volunteers: f
View:

• Adults aged 21 years or older.

• Current e-cigarette users who report e-cigarette use on ≥20 of the past 30 days.

• Former daily cigarette smokers who currently smoke on ≤19 days per month and no more than 5 cigarettes per day.

• Diagnosed with opioid use disorder (OUD).

• Currently receiving buprenorphine treatment for OUD.

Locations
United States
South Carolina
Prisma Health Recovery Clinic-Greenville
RECRUITING
Greenville
Contact Information
Primary
Irene Pericot-Valverde, PhD
iperico@clemson.edu
18549998005
Time Frame
Start Date: 2025-11-12
Estimated Completion Date: 2026-05
Participants
Target number of participants: 70
Related Therapeutic Areas
Sponsors
Collaborators: National Institute on Drug Abuse (NIDA)
Leads: Prisma Health-Upstate

This content was sourced from clinicaltrials.gov